Anteris Technologies Global Corp.
AVRNasdaqCIK 2011514HealthcareFiscal year ends Dec 31
Reports and events: 56 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2307:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-037392 |
| 2026-09-1717:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-26-037002 |
| 2026-09-0807:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-035840 |
| 2026-08-1219:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-032296 |
| 2026-08-1116:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001140361-26-032232 |
| 2026-08-0309:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-030586 |
| 2026-07-3108:38 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-030355 |
| 2026-05-2217:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-022633 |
| 2026-05-1320:55 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-26-020901 |
| 2026-05-1320:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-020896 |
| 2026-05-1216:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001140361-26-020806 |
| 2026-04-2916:47 ET | 8-K | 1.02 Termination of a material agreement | 0001140361-26-017846 |
| 2026-04-2317:13 ET | 8-K | 1.01 Entry into a material agreement | 0001140361-26-016435 |
| 2026-03-0316:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-007568 |
| 2026-02-2718:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-007003 |
| 2026-02-2616:07 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001140361-26-006977 |
| 2026-01-2917:06 ET | SCHEDULE 13D | Ownership report, active investor | 0001437749-26-002429 |
| 2026-01-2217:18 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-002070 |
| 2026-01-2206:18 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-26-001938 |
| 2025-12-1506:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-25-045444 |
| 2025-12-0406:02 ET | 8-K | 5.07 Shareholder vote results | 0001140361-25-044257 |
| 2025-12-0116:42 ET | 8-K | 1.02 Termination of a material agreement | 0001140361-25-043801 |
| 2025-11-2616:35 ET | S-1 | Registration statement | 0001140361-25-043521 |
| 2025-11-1706:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-042395 |
| 2025-11-1317:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-041723 |
| 2025-11-1216:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001140361-25-041643 |
| 2025-11-1016:52 ET | DEF 14A | Proxy statementPeriod 2025-12-03 | 0001140361-25-041377 |
| 2025-11-0307:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-040087 |
| 2025-10-2821:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-039514 |
| 2025-10-2717:26 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events | 0001140361-25-039496 |
| 2025-10-2417:10 ET | 8-K | 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-039290 |
| 2025-10-1516:49 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events | 0001140361-25-038210 |
| 2025-10-1509:29 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-038166 |
| 2025-09-2911:00 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001140361-25-036430 |
| 2025-09-1906:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-035449 |
| 2025-09-1109:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-034636 |
| 2025-09-0406:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-033879 |
| 2025-08-1806:01 ET | DEF 14A | Proxy statementPeriod 2025-09-04 | 0001140361-25-031606 |
| 2025-08-1220:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-030297 |
| 2025-08-1115:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001140361-25-030146 |
| 2025-08-0707:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-029341 |
| 2025-07-2917:19 ET | 8-K | 1.01 Entry into a material agreement | 0001140361-25-027864 |
| 2025-06-0907:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-25-021859 |
| 2025-05-1419:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-018725 |
| 2025-05-1317:22 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001140361-25-018701 |
| 2025-04-2916:34 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001140361-25-016352 |
| 2025-03-3106:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-011072 |
| 2025-03-2119:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-009748 |
| 2025-03-1318:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-008474 |
| 2025-03-1217:02 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001140361-25-008455 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 09:01 ET. Listed shows no prices and gives no investment advice.